Top Markets
Coin of the day
Apontis Pharma AG Apontis Pharma AG

Apontis Pharma AG

APPH
Kedudukan dalam Saham #21489
Operating within Germany, Apontis Pharma AG specializes in the marketing and... Operating within Germany, Apontis Pharma AG specializes in the marketing and distribution of pharmaceutical products, with a particular emphasis on internal medicine. The company is actively involved in the development, promotion, and commercialization of a diverse portfolio, which includes combination single-pill therapies and other medications. Key therapeutic areas of focus encompass cardiovascular diseases, such as high blood pressure (hypertension), elevated cholesterol (hyperlipidemia), and strategies for secondary prevention, in addition to respiratory ailments and diabetes. Established in 1946, Apontis Pharma AG maintains its corporate headquarters in Monheim am Rhein, Germany.
Harga Saham
$12.75
Disegerakkan terakhir: 2025-11-17
Modal Pasaran
$106.20M
Perubahan (1 hari)
-2.29%
Perubahan (1 tahun)
0.24%
Negara
DE
Perdagangan Apontis Pharma AG (APPH)

Kategori

Harga APPH dengan permodalan pasaran b
Apontis Pharma AG Apontis Pharma AG
APPH
$12.75
Modal pasaran bagi Apontis Pharma AG(APPH)
Modal Pasaran: $106.20M
Sehingga August 2026, Apontis Pharma AG mempunyai modal pasaran sebanyak $106.20M. Ini menjadikan Apontis Pharma AG syarikat ke-21489th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Apontis Pharma AG dari 2021 hingga 2026
APPH berbanding dengan 5 teratas yang paling popular stocks
Harga APPH Aset B Pasaran B Hasilnya
Apontis Pharma AG Apontis Pharma AG
$625,617 $106.20M
$5.211T +4,906,956.10%
Apontis Pharma AG Apontis Pharma AG
$545,830 $106.20M
$4.547T +4,281,143.20%
Apontis Pharma AG Apontis Pharma AG
$499,699 $106.20M
$4.162T +3,919,312.25%
Apontis Pharma AG Apontis Pharma AG
$431,309 $106.20M
$3.593T +3,382,893.22%
Apontis Pharma AG Apontis Pharma AG
$335,278 $106.20M
$2.793T +2,629,668.32%